BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics of mexiletine and its hydroxymethyl metabolite after intramuscular and intravenous administration of mexiletine in healthy subjects]. 1987

R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008801 Mexiletine Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties. KO-1173,KO1173,KOE-1173,Mexiletene,Mexiletine Hydrochloride,Mexitil,Mexitil PL,Mexityl,Novo-Mexiletine,KO 1173,KOE 1173,KOE1173,Novo Mexiletine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.
January 1986, European journal of clinical pharmacology,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects.
January 1990, Polish journal of pharmacology and pharmacy,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in freshwater crocodiles (Crocodylus siamensis) after intravenous and intramuscular administration.
January 2020, Journal of veterinary pharmacology and therapeutics,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of tramadol and its major metabolite after intramuscular administration in piglets.
December 2014, Journal of veterinary pharmacology and therapeutics,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses.
August 1991, British journal of clinical pharmacology,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of clentiazem after intravenous and oral administration in healthy subjects.
April 1993, Journal of clinical pharmacology,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.
October 2013, Journal of veterinary pharmacology and therapeutics,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
July 1996, American journal of veterinary research,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
[Pharmacokinetics of temocillin after intravenous and intramuscular administration].
December 1985, Casopis lekaru ceskych,
R Levy-Prades, and F Philip, and T Danays, and A Serradimigni, and J P Cano
Pharmacokinetics of chlorazepate after intravenous and intramuscular administration.
January 1983, Psychopharmacology,
Copied contents to your clipboard!